L&C Bio Co., Ltd (290650.KQ) KOE

Currency In KRW

AD

Valuation

Market Cap1.5T
Enterprise Value1.57T
P/E Ratio-9.05
PEG Ratio0.05
Price/Sales Ratio13.02
Price/Book Ratio6.66
Enterprise/Revenue13.47
Enterprise/EBITDA76.4

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-1.38
Operating Margin0.11
AD

Management Effectiveness

Return On Assets-0.29
Return On Equity-0.56

Income Statement

Revenue85.48B
Revenue/Share3,770.06
Gross Profit41.32B
EBITDA11.57B
Net Income-138.17B
Diluted EPS-5,811.4

Balance Sheet

Total Cash48.64B
Total Cash/Share1,869.18
Total Debt87.49B
Total Debt/Equity0.43
Current Ratio0.64
Book Value Per Share8,194.04

Price History

52-Week Change65.29
52-Week High125,000
52-Week Low29,100
Moving Average 50 Days75,186
Moving Average 200 Days69,898.75

Statistics

Average Volume363,467
Shares Outstanding24.61M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate50
Trailing Annual Dividend Yield0.1
Payout Ratio-0.01
Last Split Factor3:1
Last Split DateOctober 12, 2020
AD